ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NPSP (MM)

45.99
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
(MM) NASDAQ:NPSP NASDAQ Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 45.99 0.00 01:00:00

NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. Over ...

17/01/2015 1:00am

PR Newswire (US)


Nps (NASDAQ:NPSP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Nps Charts.

NEW YORK, Jan. 16, 2015 /PRNewswire/ -- Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc. ("NPS" or the "Company") (Nasdaq: NPSP) for potential breaches of fiduciary duties in connection with the sale of the Company to Shire PLC ("Shire") (Nasdaq: SHPG) for approximately $5.2 billion.  The Company's stockholders will receive $46 for each share of NPS common stock they own.

Faruqi & Faruqi, LLP.

Click here for more information: www.faruqilaw.com/NPSP. There is no cost or obligation to you.

The investigation focuses on whether NPS' Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of NPS' shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation.  The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation.  The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

If you own common stock in NPS and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/NPSP or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330. 

Contact:

Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde, Esq.
jmonteverde@faruqilaw.com
Toll Free: (877) 247-4292
Phone:   (212) 983-9330

Attorney Advertising. (C) 2015 Faruqi & Faruqi, LLP.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We are happy to discuss your particular case.

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nps-pharmaceuticals-inc-investor-alert-faruqi--faruqi-llp-announces-the-investigation-of-nps-pharmaceuticals-inc-over-the-proposed-sale-of-the-company-to-shire-plc---npsp-300021917.html

SOURCE Faruqi & Faruqi, LLP

Copyright 2015 PR Newswire

1 Year Nps Chart

1 Year Nps Chart

1 Month Nps Chart

1 Month Nps Chart